載入...
Immune response evaluation criteria in solid tumors for assessment of atypical responses after immunotherapy
In 2017, immune response evaluation criteria in solid tumors (iRECIST) were introduced to validate radiologic and clinical interpretations and to better analyze tumor’s response to immunotherapy, considering the different time of following and response, between this new therapy compared to the stand...
Na minha lista:
| 發表在: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173324/ https://ncbi.nlm.nih.gov/pubmed/34131564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v12.i5.323 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|